Who Should Consider Genetic Testing for Cancer?

Genetic testing for hereditary cancer risk is not something everyone needs, but for certain individuals, it can be a powerful tool for informed health decisions. Clinical guidelines help identify who is most likely to benefit from testing based on personal and family history patterns that suggest an inherited predisposition to cancer.

Personal History Indicators

You may want to discuss genetic testing with your healthcare provider if you have been diagnosed with:

• Breast cancer before age 50
• Ovarian, fallopian tube, or primary peritoneal cancer at any age
• Triple-negative breast cancer before age 60
• Male breast cancer at any age
• Pancreatic cancer, particularly with Ashkenazi Jewish ancestry or a family history of breast or ovarian cancer
• Colorectal or endometrial cancer diagnosed before age 50
• Multiple primary cancers in the same individual

Family History Red Flags

Even without a personal cancer diagnosis, your family history may suggest the value of genetic testing:

• A first-degree relative (parent, sibling, or child) with any of the personal history indicators listed above
• Three or more relatives on the same side of the family with the same or related cancers
• Cancer appearing across multiple generations in a pattern consistent with inherited risk
• A known pathogenic variant in a cancer susceptibility gene in your family

Ancestry Considerations

Certain populations have a higher prevalence of specific hereditary cancer gene mutations. For example, individuals of Ashkenazi Jewish descent have an approximately 1 in 40 chance of carrying a BRCA1 or BRCA2 founder mutation, compared to about 1 in 300 to 500 in the general population. Other populations with known founder mutations include Icelandic, Norwegian, Dutch, and French Canadian communities.

Understanding Risk Assessment Tools

Healthcare providers often use validated risk assessment tools to evaluate whether a patient meets clinical criteria for genetic testing. These tools consider factors such as the number of affected relatives, the types and ages of cancer diagnoses, and the individual’s ancestry.

AI-powered risk assessment tools, like the one offered by LifeShield, can guide you through a structured evaluation of your personal and family history to determine whether genetic testing may be appropriate, based on established clinical guidelines.

What If You Are Not Sure?

If you are uncertain whether your history warrants genetic testing, a brief risk assessment is a simple and confidential way to find out. The assessment asks about your personal health history, your family members’ cancer diagnoses, and your ethnic background to evaluate whether you meet guideline criteria.

Understanding the step-by-step testing process can also help you know what to expect if testing is recommended. And for a broader overview of the science, see our complete guide to genetic testing.